UK markets open in 4 hours 50 minutes
  • NIKKEI 225

    27,993.17
    +159.88 (+0.57%)
     
  • HANG SENG

    26,239.85
    +47.53 (+0.18%)
     
  • CRUDE OIL

    72.13
    +0.22 (+0.31%)
     
  • GOLD FUTURES

    1,794.30
    -4.90 (-0.27%)
     
  • DOW

    35,144.31
    +82.76 (+0.24%)
     
  • BTC-GBP

    26,790.13
    -905.72 (-3.27%)
     
  • CMC Crypto 200

    874.70
    -40.79 (-4.46%)
     
  • ^IXIC

    14,840.71
    +3.72 (+0.03%)
     
  • ^FTAS

    4,025.99
    +0.87 (+0.02%)
     

FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting